Is losartan a calcium blocker
Pro Research Analysisby 
Searched over 200M research papers
Consensus Meter
Is Losartan a Calcium Blocker?
Introduction to Losartan and Calcium Blockers
Losartan is a medication primarily used to treat high blood pressure and to protect the kidneys from damage due to diabetes. It belongs to a class of drugs known as angiotensin II receptor blockers (ARBs). Calcium channel blockers (CCBs), on the other hand, are another class of medications used to manage hypertension and other cardiovascular conditions by inhibiting the entry of calcium ions into cardiac and smooth muscle cells, which helps to relax and widen blood vessels.
Mechanism of Action of Losartan
Losartan works by blocking the action of angiotensin II, a substance in the body that causes blood vessels to tighten and narrow. By inhibiting the angiotensin II type 1 receptor, losartan helps to relax blood vessels, thereby lowering blood pressure and improving blood flow . This mechanism is distinct from that of calcium channel blockers, which directly affect calcium ion entry into cells.
Losartan and Calcium Channel Blockers: Comparative Studies
Several studies have compared the effects of losartan with those of calcium channel blockers. For instance, a study examining the combination of losartan with hydrochlorothiazide (a diuretic) versus a combination of amlodipine (a calcium channel blocker) with an ARB found that both combinations were effective in improving left ventricular relaxation in hypertensive patients. Another study demonstrated that the pharmacokinetics of losartan and amlodipine, when administered together, were bioequivalent to their separate administration, indicating that they can be effectively combined for hypertension management.
Renal and Cardiovascular Outcomes
Research has shown that losartan has significant renal protective effects, particularly in patients with chronic kidney disease and diabetes. For example, losartan was found to reduce proteinuria and slow the progression of renal disease in patients with type 2 diabetes and nephropathy, effects that were not observed with amlodipine . Additionally, losartan has been shown to improve insulin sensitivity and glucose homeostasis in diabetic patients, further distinguishing its benefits from those of calcium channel blockers.
Conclusion
In summary, losartan is not a calcium channel blocker. It is an angiotensin II receptor blocker that works through a different mechanism to lower blood pressure and provide renal and cardiovascular protection. While both losartan and calcium channel blockers are effective in managing hypertension, their mechanisms of action and additional benefits differ significantly.
Sources and full results
Most relevant research papers on this topic